The Impact of Myomectomy on IVF Outcomes
NCT05932082 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 792
Last updated 2023-08-04
Summary
In 2% to 3% infertility women, myoma is the only factor relevant to their infertility. However, the effects of intramural myoma on fertility are controversial. For infertile women with intramural myoma (types IV, V, VI of FIGO system) of 4 to 6 cm diameter, it is not clear whether myomectomy could improve pregnancy outcomes, especially in women undergoing ART. Besides, rigorous clinical research is needed to explore the changes and relevant biomarkers of endometrial receptivity through multi-omics study in patients undergoing myomectomy and ART treatment.
Method Intervention and follow-up: (1) For the control group, evaluation protocols such as salpingography and/or laparoscopic tubal fluxation should be implemented to identify disorders such as hydrosalpinx. (2) Imaging evaluation: all pelvic MRI were performed. Other options such as transvaginal ultrasound are not excluded, but won't replace MRI. Enhanced MRI or DWI may be considered, but are not always required. (3) Surgical intervention: laparoscopic myomectomy is preferred, and abdominal myomectomy is also acceptable. (4) IVF treatment: the IVF regimen should include detailed records of the downregulation plan, number of cycles, frozen or fresh blastocysts.
Study endpoints
(1) Primary study endpoint: Live birth rate after IVF. (2) Secondary study endpoints: Clinical pregnancy rate after IVF; Cumulative pregnancy rate after IVF; Biochemical pregnancy rate after IVF; Sustained pregnancy rate after IVF (≥20 weeks); Miscarriage rate after IVF; Cycles of IVF; Pregnancy-related complications; Perinatal maternal and neonatal complications. (3) Exploratory endpoints: The correlation between imaging index and assisted reproductive outcomes, including endometrial thickness, uterine volume, type of endometrial echo, uterine contraction; endometrial vascular index (VI), flow index (FI), tubular flow index (VFI); uterine artery pulsation index (PI), uterine artery resistance index (RI), systolic/diastolic blood pressure of uterine artery (S/D).
The correlation between endometrial receptivity and assisted reproductive outcomes is analyzed based on transcriptomics, metabolomics, methylation and proteomics in samples from peripheral blood, endometrial biopsy, endometrial exfoliated cells, cervical exfoliated cells and myoma.
Conditions
- Myoma;Uterus
- IVF
- Surgery
Interventions
- PROCEDURE
-
myomectomy or not
The study group receive myomectomy, while the control group don't receive myomectomy.
Sponsors & Collaborators
-
Peking Union Medical College Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-09-01
- Primary Completion
- 2025-09-01
- Completion
- 2026-09-01
More Related Trials
-
Fertility After Myomectomy Versus Uterine Artery Embolization for Symptomatic Uterine Fibroids
NCT02577055 ·Status: COMPLETED ·Phase: NA
-
IVF Outcome Following Treatment With Ulipristal Acetate for Myomatous Uterus After at Least One IVF Failure
NCT02601196 ·Status: UNKNOWN ·Phase: PHASE4
-
To Prevent Type I-II Myoma After TCRM Recurrence by Gonadotropin-releasing Hormone (GnRH )Analogues or Mifepristone
NCT05898321 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Endometrial Biopsy Prior to IVF in Those Patients With Prior Implantation Failure
NCT01800513 ·Status: UNKNOWN ·Phase: NA
-
Endometrial and Myometrial Changes, With and Without Fibroids
NCT01671215 ·Status: WITHDRAWN
-
Somatic Stem Cells in Leiomyomas?
NCT01592903 ·Status: COMPLETED
-
Clinical Trial of Uterine Artery Embolization for Uterine Leiomyoma
NCT00821275 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids)
NCT00332033 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Therapeutic Effect and Safety of Mifepristone in the Treatment of Adenomyosis
NCT03520439 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Prognosis of Low-grade Endometrial Stromal Sarcoma
NCT05310318 ·Status: UNKNOWN
-
Pregnancy Outcomes in Infertile Patients After Treatment With Ulipristal Acetate.
NCT03533907 ·Status: COMPLETED
-
Fertility After Uterine Artery Embolisation for the Treatment of Leiomyomas
NCT00839722 ·Status: COMPLETED ·Phase: PHASE2
-
Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids
NCT00100191 ·Status: COMPLETED ·Phase: PHASE3
-
Reproductive Outcome of EM Treated by GnRH-a Associated With Laparoscopy
NCT02779387 ·Status: UNKNOWN ·Phase: NA
-
Laparoscopic Therapy of Endometrioma: Sclerotherapy vs Cystectomy in Patients With Unfinished Reproductive Plans
NCT05801523 ·Status: RECRUITING ·Phase: NA
-
Characterisation of Uterine Fibroid Tissue Stiffness
NCT03369600 ·Status: UNKNOWN ·Phase: NA
-
Development of a Microbiome Non-invasive Diagnosis Tool
NCT03330444 ·Status: COMPLETED
-
Catheter-directed Sclerotherapy Versus Surgical Resecction: Randomized Controlled Trial Comparing Ovarian Function and Therapeutic Efficacy After Treatment of Ovarian Endometrioma
NCT05279209 ·Status: UNKNOWN ·Phase: NA
-
Fertility After Uterine Artery Embolization
NCT05271981 ·Status: COMPLETED
-
IVF Versus Surgery for Endometriosis Related Infertility
NCT04743167 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Home Examinations Researching and Understanding Submucosal Evaluations
NCT05004870 ·Status: WITHDRAWN ·Phase: NA
-
Prospective Validation Study of a Uterine Fibroid-Related Infertility Prediction Model
NCT07177534 ·Status: NOT_YET_RECRUITING
-
Study to Evaluate the Safety and Effectiveness of MRgFUS Compared With Myomectomy for the Treatment of Uterine Fibroids
NCT01328067 ·Status: WITHDRAWN ·Phase: NA
-
ExAblate Treatment of Uterine Fibroids for Fertility Enhancement
NCT00730886 ·Status: TERMINATED ·Phase: NA
-
Prospective Clinical Trial on the Impact of Uterine Firomatosis on Pelvic Floor.
NCT07180524 ·Status: RECRUITING